Hopf point analysis for angiogenesis models

From MaRDI portal
Revision as of 17:51, 31 January 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:1430337

DOI10.3934/DCDSB.2004.4.29zbMath1051.34059OpenAlexW2167481327MaRDI QIDQ1430337

L. Arakelyan, Peteris Daugulis, Yuval Ginosar, Zvia Agur

Publication date: 27 May 2004

Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.3934/dcdsb.2004.4.29




Related Items (22)

Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)Dynamics of a data based ovarian cancer growth and treatment model with time delayAngiogenesis model with Erlang distributed delaysA bi-parametric model for the tumour angiogenesis and antiangiogenesis therapyOptimal control with isoperimetric constraint for chemotherapy of tumorsThe nature of Hopf bifurcation for the Gompertz model with delaysThe role of mechanical host-tumour interactions in the collapse of tumour blood vessels and tumour growth dynamicsModeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesisOn the role of endothelial progenitor cells in tumor neovascularizationAnalysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delaysOn an extension of a mathematical model for tumor anti-angiogenesisTime delay in physiological systems: analyzing and modeling its impactWhat mathematical models can or cannot do in glioma description and understandingOn dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapiesChemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruningTractable Model of Malignant Gliomas Immunotherapy with Discrete Time DelaysIntensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment ImprovementSimulation of tumor response to immunotherapy using a hybrid cellular automata modelOptimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesisVascular phenotype identification and anti-angiogenic treatment recommendation: a pseudo-multiscale mathematical model of angiogenesisTumor Development Under Combination Treatments with Anti-angiogenic TherapiesA three-dimensional angiogenesis model with time-delay







This page was built for publication: Hopf point analysis for angiogenesis models